World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

OxiWear Announces Medicare and Insurance Coverage Expansion for Continuous Oxygen Measuring Device

Cision PR Newswire by Cision PR Newswire
June 11, 2026
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

ARLINGTON, Va., June 11, 2026 /PRNewswire/ — OxiWear, the FDA-cleared wearable medical device company dedicated to protecting patients with hypoxia, today announced that eligible patients may now access OxiWear through Medicare and participating insurance providers, helping expand access to continuous oxygen measurement for individuals living with chronic respiratory, cardiovascular, and other conditions with associated hypoxia.

OxiWear worn by patients with diverse skin tones

OxiWear is the first FDA-cleared wearable device designed to provide continuous blood oxygen measurement and real-time low-oxygen alerts during both motion and rest, with proven accuracy across all skin tones. The device enables patients and healthcare providers to identify oxygen desaturation that may otherwise go undetected, helping to improve patient safety, support proactive care, and provide greater peace of mind.

The availability of Medicare and insurance coverage marks a significant milestone in OxiWear’s mission to make advanced oxygen measuring more accessible and affordable for patients who need it most.

“I started OxiWear as a personal mission to help people like me live life to the fullest despite the challenges of living with conditions that put us at risk of low oxygen levels,” said Shavini Fernando, Founder and CEO of OxiWear. “Since receiving FDA clearance, one of our biggest priorities has been solving the reimbursement challenge and ensuring patients can access this technology without creating an additional financial burden. I’m incredibly proud that we’ve been able to work through those barriers and make OxiWear available through insurance coverage. Now, more patients can access the continuous oxygen data they need with greater affordability and peace of mind.”

OxiWear received FDA clearance as a prescription medical device for continuous blood oxygen measurement in both clinical and at-home settings. As part of the FDA review process, OxiWear demonstrated high performance across diverse skin tones, helping address longstanding concerns regarding disparities in pulse oximetry accuracy and ensuring more equitable oxygen measurement for all patients.

The device is designed to support patients with conditions including pulmonary hypertension, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), cardiovascular disease, sleep-related breathing disorders, and other conditions that may result in oxygen desaturation.

Healthcare providers are increasingly recognizing the importance of the continuous measurement of oxygen beyond traditional spot-check pulse oximetry, particularly for patients whose oxygen levels may fluctuate during daily activities, exercise, rehabilitation, and sleep. OxiWear’s ability to provide continuous measurements during both motion and rest offers clinicians and patients a more complete picture of oxygen status throughout the day.

By expanding reimbursement access through Medicare and participating insurance plans, OxiWear aims to improve patient outcomes, reduce avoidable hospitalizations, lower healthcare costs, and provide greater peace of mind for patients, caregivers, and healthcare providers.

For additional information regarding eligibility, reimbursement, and prescribing information, visit www.oxiwear.com or contact the OxiWear team directly.

About OxiWear: OxiWear is a Virginia-based medical technology company focused on reducing patient vulnerability to hypoxia through continuous oxygen measurements and real-time low-oxygen alerts. Founded by pulmonary hypertension patient and entrepreneur Shavini Fernando, OxiWear’s mission is to improve patient safety, reduce healthcare costs, and empower patients and clinicians with actionable oxygen data in both clinical and home settings.

OxiWear Device and App

OxiWear

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oxiwear-announces-medicare-and-insurance-coverage-expansion-for-continuous-oxygen-measuring-device-302796498.html

SOURCE OxiWear

Cision PR Newswire

Cision PR Newswire

Related Posts

How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

November 21, 2026

Mendez & Sanchez Finds Three Counties Accounted for Nearly Two-Thirds of California Rideshare Trips

November 21, 2026

Highmark Health Reports Revenue of $26.5 billion, $741 million in Operating Income, for Nine Months ended Sept. 30, 2026

November 20, 2026

AZ Blue Health Choice Expands Access to Resources for Page Families

November 20, 2026

Payoneer Receives OCC Conditional Approval to Form Stablecoin National Trust Bank

November 20, 2026

S&P Global to Present at Goldman Sachs Financial Services Conference on December 8, 2026

November 20, 2026

Popular News

  • How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

    0 shares
    Share 0 Tweet 0
  • Mendez & Sanchez Finds Three Counties Accounted for Nearly Two-Thirds of California Rideshare Trips

    0 shares
    Share 0 Tweet 0
  • Highmark Health Reports Revenue of $26.5 billion, $741 million in Operating Income, for Nine Months ended Sept. 30, 2026

    0 shares
    Share 0 Tweet 0
  • AZ Blue Health Choice Expands Access to Resources for Page Families

    0 shares
    Share 0 Tweet 0
  • Payoneer Receives OCC Conditional Approval to Form Stablecoin National Trust Bank

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler